395 related articles for article (PubMed ID: 22213492)
1. Evaluation of guideline recommendations on oral medications for type 2 diabetes mellitus: a systematic review.
Bennett WL; Odelola OA; Wilson LM; Bolen S; Selvaraj S; Robinson KA; Bass EB; Puhan MA
Ann Intern Med; 2012 Jan; 156(1 Pt 1):27-36. PubMed ID: 22213492
[TBL] [Abstract][Full Text] [Related]
2. Systematic review: comparative effectiveness and safety of oral medications for type 2 diabetes mellitus.
Bolen S; Feldman L; Vassy J; Wilson L; Yeh HC; Marinopoulos S; Wiley C; Selvin E; Wilson R; Bass EB; Brancati FL
Ann Intern Med; 2007 Sep; 147(6):386-99. PubMed ID: 17638715
[TBL] [Abstract][Full Text] [Related]
3. Comparative effectiveness and safety of medications for type 2 diabetes: an update including new drugs and 2-drug combinations.
Bennett WL; Maruthur NM; Singh S; Segal JB; Wilson LM; Chatterjee R; Marinopoulos SS; Puhan MA; Ranasinghe P; Block L; Nicholson WK; Hutfless S; Bass EB; Bolen S
Ann Intern Med; 2011 May; 154(9):602-13. PubMed ID: 21403054
[TBL] [Abstract][Full Text] [Related]
4. Systematic review of current guidelines, and their evidence base, on risk of lactic acidosis after administration of contrast medium for patients receiving metformin.
Goergen SK; Rumbold G; Compton G; Harris C
Radiology; 2010 Jan; 254(1):261-9. PubMed ID: 20032157
[TBL] [Abstract][Full Text] [Related]
5. AHRQ's comparative effectiveness research on oral medications for type 2 diabetes: a summary of the key findings.
Bennett WL; Balfe LM; Faysal JM
J Manag Care Pharm; 2012; 18(1 Suppl A):1-22. PubMed ID: 22313233
[TBL] [Abstract][Full Text] [Related]
6. Initial choice of oral glucose-lowering medication for diabetes mellitus: a patient-centered comparative effectiveness study.
Berkowitz SA; Krumme AA; Avorn J; Brennan T; Matlin OS; Spettell CM; Pezalla EJ; Brill G; Shrank WH; Choudhry NK
JAMA Intern Med; 2014 Dec; 174(12):1955-62. PubMed ID: 25347323
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of guidelines on diabetes medication.
Giaccari A; Giorda CB; Riccardi G; De Micheli A; Bruno G; Monge L; Frontoni S
Ann Intern Med; 2012 May; 156(10):752-3; author reply 753. PubMed ID: 22586015
[No Abstract] [Full Text] [Related]
8. Evaluation of guidelines on diabetes medication.
Brown K; Harbour R; Petrie J
Ann Intern Med; 2012 May; 156(10):752; author reply 753. PubMed ID: 22586014
[No Abstract] [Full Text] [Related]
9. Oral antidiabetic agents: current role in type 2 diabetes mellitus.
Krentz AJ; Bailey CJ
Drugs; 2005; 65(3):385-411. PubMed ID: 15669880
[TBL] [Abstract][Full Text] [Related]
10. Thiazolidinediones in type 2 diabetes: a cardiology perspective.
Khanderia U; Pop-Busui R; Eagle KA
Ann Pharmacother; 2008 Oct; 42(10):1466-74. PubMed ID: 18698014
[TBL] [Abstract][Full Text] [Related]
11. Capitalizing on prescribing pattern variation to compare medications for type 2 diabetes.
Prentice JC; Conlin PR; Gellad WF; Edelman D; Lee TA; Pizer SD
Value Health; 2014 Dec; 17(8):854-62. PubMed ID: 25498781
[TBL] [Abstract][Full Text] [Related]
12. Oral pharmacologic treatment of type 2 diabetes mellitus: a clinical practice guideline from the American College of Physicians.
Qaseem A; Humphrey LL; Sweet DE; Starkey M; Shekelle P;
Ann Intern Med; 2012 Feb; 156(3):218-31. PubMed ID: 22312141
[TBL] [Abstract][Full Text] [Related]
13. Pioglitazone/metformin (Actoplus met).
Med Lett Drugs Ther; 2006 Jan; 48(1227):9-11. PubMed ID: 16444136
[No Abstract] [Full Text] [Related]
14. The relationship of guideline-concordant depression treatment and patient adherence to oral diabetes medications.
Nau DP; Chao J; Aikens JE
Res Social Adm Pharm; 2005 Sep; 1(3):378-88. PubMed ID: 17138485
[TBL] [Abstract][Full Text] [Related]
15. Clinical guidelines and payer policies on fusion for the treatment of chronic low back pain.
Cheng JS; Lee MJ; Massicotte E; Ashman B; Gruenberg M; Pilcher LE; Skelly AC
Spine (Phila Pa 1976); 2011 Oct; 36(21 Suppl):S144-63. PubMed ID: 21952186
[TBL] [Abstract][Full Text] [Related]
16. Guideline-conformity of initiation with oral hypoglycemic treatment for patients with newly therapy-dependent type 2 diabetes mellitus in Austria.
Winkelmayer WC; Stedman MR; Pogantsch M; Wieninger P; Bucsics A; Asslaber M; Bauer R; Burkhardt T; Schautzer A; Brookhart MA;
Pharmacoepidemiol Drug Saf; 2011 Jan; 20(1):57-65. PubMed ID: 21182153
[TBL] [Abstract][Full Text] [Related]
17. Self blood glucose monitoring in type 2 diabetes. A financial impact analysis based on UK primary care.
Belsey JD; Pittard JB; Rao S; Urdahl H; Jameson K; Dixon T
Int J Clin Pract; 2009 Mar; 63(3):439-48. PubMed ID: 19222629
[TBL] [Abstract][Full Text] [Related]
18. [Status of glitazones in treatment of type 2 diabetes mellitus].
Willeke A
Internist (Berl); 2007 Jul; 48(7):749; author reply 749-50. PubMed ID: 17571246
[No Abstract] [Full Text] [Related]
19. Management of type 2 diabetes using non-insulin glucose-lowering therapies: a critical appraisal of clinical practice guidelines with the AGREE II instrument.
Lam WMJ; Al-Khalifah R; Florez ID; Cruz-Lopes L; Sekercioglu MF; Couban R; Fu R; Cherney DZI; Sekercioglu N
Diabet Med; 2020 Apr; 37(4):636-647. PubMed ID: 31943344
[TBL] [Abstract][Full Text] [Related]
20. Quality of clinical practice guidelines for glycemic control in type 2 diabetes mellitus.
Holmer HK; Ogden LA; Burda BU; Norris SL
PLoS One; 2013; 8(4):e58625. PubMed ID: 23577058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
